GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ishita Drugs And Industries Ltd (BOM:524400) » Definitions » Debt-to-EBITDA

Ishita Drugs And Industries (BOM:524400) Debt-to-EBITDA : 0.00 (As of Dec. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Ishita Drugs And Industries Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ishita Drugs And Industries's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0.0 Mil. Ishita Drugs And Industries's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0.0 Mil. Ishita Drugs And Industries's annualized EBITDA for the quarter that ended in Dec. 2024 was ₹14.6 Mil. Ishita Drugs And Industries's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Ishita Drugs And Industries's Debt-to-EBITDA or its related term are showing as below:

BOM:524400' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.02   Med: 0.27   Max: 3.12
Current: 1.68

During the past 13 years, the highest Debt-to-EBITDA Ratio of Ishita Drugs And Industries was 3.12. The lowest was 0.02. And the median was 0.27.

BOM:524400's Debt-to-EBITDA is ranked worse than
50.97% of 673 companies
in the Drug Manufacturers industry
Industry Median: 1.59 vs BOM:524400: 1.68

Ishita Drugs And Industries Debt-to-EBITDA Historical Data

The historical data trend for Ishita Drugs And Industries's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ishita Drugs And Industries Debt-to-EBITDA Chart

Ishita Drugs And Industries Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.32 0.03 - 1.02 -

Ishita Drugs And Industries Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 1.82 -

Competitive Comparison of Ishita Drugs And Industries's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Ishita Drugs And Industries's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ishita Drugs And Industries's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ishita Drugs And Industries's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Ishita Drugs And Industries's Debt-to-EBITDA falls into.


;
;

Ishita Drugs And Industries Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ishita Drugs And Industries's Debt-to-EBITDA for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / 11.612
=0.00

Ishita Drugs And Industries's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / 14.568
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2024) EBITDA data.


Ishita Drugs And Industries  (BOM:524400) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Ishita Drugs And Industries Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Ishita Drugs And Industries's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Ishita Drugs And Industries Business Description

Traded in Other Exchanges
N/A
Address
C.G.Road, 401, 3rd Eye -II, Opposite Parimal Garden, Ahmedabad, GJ, IND, 380006
Ishita Drugs And Industries Ltd is engaged in the business of manufacturing various APIs and drug intermediates. It manufactures high quality products and is known for its ethical dealings in business. The company supplies its products to various pharmaceutical companies and is also being exported to various countries across the world. The company has three manufacturing facilities located in the state of Gujarat, two for APIs and drug intermediates at Ahmedabad and Surendranagar and one for finished pharmaceutical formulations at Mehsana.

Ishita Drugs And Industries Headlines

No Headlines